Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. All clinical decisions regarding sermorelin therapy are made by independent licensed clinicians based on individual health profiles. Consult a qualified healthcare professional before beginning any therapy. New Blue Health is a technology and administrative services platform, not a medical provider.

Sermorelin Online — What Clinical Review Actually Means Before Therapy

If you've searched for sermorelin online, you've probably encountered dozens of sites that make the process sound like ordering supplements from Amazon. Add to cart, check out, wait for a box. That framing is misleading — and potentially dangerous. A legitimate sermorelin pathway involves a real clinical review by an independent licensed clinician, and understanding what that review entails is the difference between informed healthcare and a gamble. This article breaks down what actually happens during that process, who makes the decisions, and why the evaluation step exists in the first place.

What Is Sermorelin and Why Is It Discussed in Metabolic and Longevity Contexts?

Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) — specifically, it consists of the first 29 amino acids of the 44-amino-acid GHRH sequence. It was originally studied for diagnostic and therapeutic use related to growth hormone deficiency. Unlike exogenous growth hormone itself, sermorelin stimulates the pituitary gland to produce and release growth hormone endogenously, which is why some clinicians consider it a more physiologically aligned approach.

Interest in sermorelin has grown within metabolic health and recovery contexts. Walker et al. (2006) demonstrated that GHRH analogs could improve body composition markers in older adults with relative growth hormone insufficiency. Separate work by Vittone et al. (1997) examined GHRH administration and its effects on sleep-related growth hormone secretion in aging populations. These studies don't prove sermorelin works for every individual — they provide clinical context for why licensed clinicians may consider it as part of a broader evaluation.

For a deeper look at the published literature, New Blue Health maintains an evidence summary for sermorelin that references specific studies and their limitations.

Why Clinical Review Matters — It's Not Just a Checkout Process

Clinical review is the process by which a licensed clinician evaluates whether a specific therapy is appropriate for a specific person. It is not a formality, and it is not a rubber stamp. Some people who complete an intake will not be prescribed sermorelin — and that's the system working correctly.

Here's why this step carries real weight. Sermorelin acts on the hypothalamic-pituitary axis. A clinician needs to understand your baseline health, any contraindications, current medications, and whether your symptoms actually align with a profile that might benefit from GHRH stimulation. Someone with an active malignancy, for instance, would generally not be a candidate for therapies that influence growth hormone pathways. Neither would someone whose symptoms are better explained by thyroid dysfunction, sleep apnea, or another condition entirely.

The clinical review also serves a legal and ethical function. Prescribing a compounded peptide without adequate evaluation exposes both the patient and the clinician to risk. Platforms that skip or minimize this step aren't doing you a favor — they're cutting a corner that exists for your protection.

Step-by-Step: The Telehealth Intake Process

The intake process through New Blue Health follows a structured sequence. Here's what it looks like in practice:

1. Choose a pathway. You select the treatment category you're interested in — in this case, Recovery/Performance, which includes sermorelin.

2. Complete the health intake. This is a detailed questionnaire covering medical history, current medications, allergies, symptoms, and relevant lifestyle factors. It's not a three-question form. Expect to spend time on it.

3. Pay the consultation fee. A $75 consultation fee is collected separately from any medication cost. This fee is non-refundable regardless of the outcome. It covers the licensed clinician's time and evaluation — not a guaranteed prescription.

4. Clinician review. An independent licensed clinician reviews your intake. They may request additional information, ask follow-up questions, or schedule a synchronous consultation depending on the complexity of your case.

5. Clinical decision. If appropriate, the clinician may prescribe sermorelin. If not, they won't. The decision is theirs alone.

6. Pharmacy fulfillment. If prescribed, the medication is compounded at a state-licensed 503A pharmacy and shipped directly to you with all necessary supplies.

That's it. No auto-ship without evaluation. No prescription before review.

What a Licensed Clinician Evaluates During Review

A licensed clinician reviewing a sermorelin intake is looking at several domains simultaneously. While specific evaluation criteria vary by clinician and patient, the general framework includes:

The clinician isn't working from a checklist that auto-approves anyone who answers "yes" to enough questions. They're making a judgment call based on clinical training and the totality of the information provided. This is also why the $75 consultation fee is non-refundable — the clinician performs real work regardless of the outcome.

Understanding the Role of 503A Compounding Pharmacies

Compounded sermorelin is prepared at state-licensed 503A compounding pharmacies. These pharmacies operate under state board of pharmacy oversight and compound medications pursuant to individual patient prescriptions. This is fundamentally different from mass-manufactured pharmaceuticals.

Compounded medications are prepared to order, not commercially manufactured. They are not evaluated through the same regulatory pathway as branded drugs. This doesn't mean they're unregulated — 503A pharmacies must comply with USP <797> and <800> standards for sterile and hazardous compounding, respectively, and are subject to state inspections. But it does mean the patient should understand the distinction.

New Blue Health maintains a compounding disclosure page that explains this in detail. If you're evaluating any telehealth platform for peptide therapy, asking about their pharmacy sourcing is one of the most important questions you can raise. A guide on how to evaluate a peptide provider covers additional criteria worth checking.

Platform vs. Provider — Understanding Who Does What

This distinction matters more than most people realize. New Blue Health is a technology and administrative services platform, not a medical provider. The platform facilitates intake, coordinates care logistics, and manages the administrative relationship between patients, clinicians, and pharmacies. It does not prescribe medications. It does not make clinical decisions. It does not override a clinician's judgment.

The licensed clinicians who review intakes are independent. They are credentialed, licensed in the states where they practice, and make prescribing decisions based solely on clinical appropriateness. Andy Palenzuela, who founded New Blue Health after 14+ years in regulated health product supply chains, has been explicit that the platform's role is coordination and compliance infrastructure — not clinical authority.

This separation exists for good reason. When a platform also acts as the prescriber, incentive alignment gets murky. Does the entity making the prescribing decision also benefit financially from every prescription written? That's a conflict worth scrutinizing. The platform-provider separation at New Blue Health is designed to keep clinical decisions independent of commercial pressure.

The platform holds LegitScript certification, which involves verification of business practices, regulatory compliance, and operational transparency. You can learn more about the team's approach on the about page.

Availability, Pricing, and What to Expect

Sermorelin through New Blue Health is available in 48 states (Alabama and Mississippi excluded). Pricing is posted transparently:

The $75 consultation fee is always separate and non-refundable. All orders include the telehealth consultation, prescription (if prescribed), compounded medication, supplies, and shipping.

For context, some competing platforms bundle the consultation fee into the medication price, which obscures the actual cost structure. Others charge consultation fees north of $150. The posted pricing at New Blue Health includes everything except the consultation — no hidden fees for syringes, shipping, or "membership."

If you're weighing sermorelin against other recovery-focused peptides, New Blue Health also offers tesamorelin ($299/30-day, $849/90-day). A comparison between tesamorelin and sermorelin can help clarify which pathway a clinician might consider more appropriate based on your profile.

Common Misconceptions About Telehealth Sermorelin Access

"Everyone gets approved." They don't. Eligibility depends on clinical review. Some intakes result in a clinician declining to prescribe, requesting additional information, or recommending a different approach entirely.

"It's the same as buying a supplement." Sermorelin is a prescription medication. It requires a clinician's evaluation and a valid prescription. Platforms that sell it without clinical review are operating outside appropriate medical standards.

"Telehealth means lower standards." Not inherently. The clinical evaluation performed via telehealth follows the same prescribing standards as an in-person visit. The modality is different; the clinical rigor shouldn't be. New Blue Health's medical review policy outlines how clinical content and processes are overseen.

"Compounded means unregulated." Compounded medications are regulated at the state level. 503A pharmacies operate under state board oversight, follow USP compounding standards, and are subject to inspection. "Compounded" and "unregulated" are not synonyms.

Questions to Ask Your Clinician Before Starting Therapy

Before beginning any peptide therapy, consider asking your clinician these questions during your consultation:

• Based on my intake, what specifically makes me a potential candidate for sermorelin — or not?
• Are there lab tests you'd recommend before or during therapy?
• What realistic outcomes should I expect, and over what timeframe?
• Are there interactions with my current medications I should be aware of?
• How will we monitor progress, and what would prompt a change in approach?
• What side effects should I watch for, and when should I contact you?

These aren't gotcha questions. They're the baseline for informed consent. A clinician who can't or won't answer them is a red flag worth heeding.

Frequently Asked Questions

What does clinical review mean for sermorelin via telehealth?

Clinical review means an independent licensed clinician evaluates your health history, symptoms, and relevant information to determine whether sermorelin therapy may be appropriate for you. Not everyone qualifies — eligibility depends on clinical review. New Blue Health facilitates the intake and care coordination process as a technology platform but does not make medical decisions.

What is the regulatory status of compounded medications?

Compounded sermorelin is prepared at state-licensed 503A compounding pharmacies. It is not the same as a commercially manufactured branded medication. Your clinician can discuss what this means for your care during your consultation.

How long does the consultation take?

Consultation timing varies by clinician availability. After you complete your intake through the platform, an independent licensed clinician will review your information and conduct an evaluation. New Blue Health coordinates this process but does not control clinician scheduling.

Does everyone who applies get prescribed sermorelin?

No. Eligibility depends on clinical review by an independent licensed clinician. If appropriate, a licensed clinician may prescribe sermorelin. The clinical decision is made independently based on your individual health profile.

What does the $75 consultation fee cover, and is it refundable?

The $75 consultation fee covers the clinical evaluation by an independent licensed clinician. It is separate from the medication price and is non-refundable. This fee applies regardless of the outcome of the clinical review.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. All clinical decisions are made by independent licensed clinicians. New Blue Health is a technology and administrative services platform, not a medical provider. Individual results vary, and eligibility for any therapy depends on clinical review. Consult a qualified healthcare professional before starting any treatment.

Written by Andy Palenzuela — founder of New Blue Health, with 14+ years in regulated health product supply chains. Learn more about the clinical content team.